🇪🇺 C. difficile vaccine formulation 1. in European Union

C. difficile vaccine formulation 1. (c-difficile-vaccine-formulation-1) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

C. difficile vaccine formulation 1. in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is C. difficile vaccine formulation 1. approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for C. difficile vaccine formulation 1. in European Union?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.